Antonio Palumbo
Antonio Palumbo
Universitŕ di Torino; Torino Italy
Verified email at unito.it
TitleCited byYear
Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma
JF San Miguel, R Schlag, NK Khuageva, MA Dimopoulos, O Shpilberg, ...
New England Journal of Medicine 359 (9), 906-917, 2008
18602008
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
SV Rajkumar, MA Dimopoulos, A Palumbo, J Blade, G Merlini, MV Mateos, ...
The lancet oncology 15 (12), e538-e548, 2014
12722014
Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial
A Palumbo, S Bringhen, T Caravita, E Merla, V Capparella, V Callea, ...
The Lancet 367 (9513), 825-831, 2006
9192006
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem …
M Cavo, P Tacchetti, F Patriarca, MT Petrucci, L Pantani, M Galli, ...
The Lancet 376 (9758), 2075-2085, 2010
7362010
Prevention of thalidomide-and lenalidomide-associated thrombosis in myeloma
A Palumbo, SV Rajkumar, MA Dimopoulos, PG Richardson, J San Miguel, ...
Leukemia 22 (2), 414, 2008
7212008
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
A Dispenzieri, R Kyle, G Merlini, JS Miguel, H Ludwig, R Hajek, ...
Leukemia 23 (2), 215, 2009
6712009
Carfilzomib, lenalidomide, and dexamethasone for relapsed multiple myeloma
AK Stewart, SV Rajkumar, MA Dimopoulos, T Masszi, I Špička, A Oriol, ...
New England Journal of Medicine 372 (2), 142-152, 2015
6682015
Elotuzumab therapy for relapsed or refractory multiple myeloma
S Lonial, M Dimopoulos, A Palumbo, D White, S Grosicki, I Spicka, ...
New England Journal of Medicine 373 (7), 621-631, 2015
6352015
Continuous lenalidomide treatment for newly diagnosed multiple myeloma
A Palumbo, R Hajek, M Delforge, M Kropff, MT Petrucci, J Catalano, ...
New England Journal of Medicine 366 (19), 1759-1769, 2012
6122012
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study
SK Kumar, JH Lee, JJ Lahuerta, G Morgan, PG Richardson, J Crowley, ...
Leukemia 26 (1), 149, 2012
5762012
MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis
F Pichiorri, SS Suh, M Ladetto, M Kuehl, T Palumbo, D Drandi, C Taccioli, ...
Proceedings of the National Academy of Sciences 105 (35), 12885-12890, 2008
5752008
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and …
RA Kyle, BGM Durie, SV Rajkumar, O Landgren, J Bladé, G Merlini, ...
Leukemia 24 (6), 1121, 2010
5652010
A comparison of allografting with autografting for newly diagnosed myeloma
B Bruno, M Rotta, F Patriarca, N Mordini, B Allione, F Carnevale-Schianca, ...
New England Journal of Medicine 356 (11), 1110-1120, 2007
5332007
Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1
SV Rajkumar, JL Harousseau, B Durie, KC Anderson, M Dimopoulos, ...
Blood, blood-2010-10-299487, 2011
5312011
Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label …
J San Miguel, K Weisel, P Moreau, M Lacy, K Song, M Delforge, L Karlin, ...
The lancet oncology 14 (11), 1055-1066, 2013
5282013
Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke
MAS Trial—Italy
The Lancet 346 (8989), 1509-1514, 1995
5271995
Targeting CD38 with daratumumab monotherapy in multiple myeloma
HM Lokhorst, T Plesner, JP Laubach, H Nahi, P Gimsing, M Hansson, ...
New England Journal of Medicine 373 (13), 1207-1219, 2015
5182015
Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple …
A Palumbo, S Bringhen, D Rossi, M Cavalli, A Larocca, R Ria, M Offidani, ...
Journal of Clinical Oncology 28 (34), 5101-5109, 2010
4932010
Revised international staging system for multiple myeloma: a report from International Myeloma Working Group
A Palumbo, H Avet-Loiseau, S Oliva, HM Lokhorst, H Goldschmidt, ...
Journal of clinical oncology 33 (26), 2863, 2015
4382015
Bortezomib plus melphalan and prednisone compared with melphalan and prednisone in previously untreated multiple myeloma: updated follow-up and impact of subsequent therapy in …
MV Mateos, JF San Miguel
American Society of Clinical Oncology, 2010
4332010
The system can't perform the operation now. Try again later.
Articles 1–20